top of page
Leading the Way in Intratumoral Radiotherapeutics
News
Categories
Sign up
Featured Posts
Archive
Follow Us
Alpha-emitting Radiation Therapy Could Create a Paradigm Shift in Cancer Treatment
As the new Chief Medical Officer of Alpha Tau Medical, I passionately believe that the success of our new alpha-emitting radiation...
Feb 11, 2020
Alpha DaRT treatment proves a success in first-in-human trial
Diffusing alpha-emitters radiation therapy (DaRT) uses interstitial radioactive seeds that continually release short-lived alpha-emitting...
Jan 27, 2020
Israel's alpha radiation treatment shows tumor shrinkage in 100% of cases
Cancer is the second leading cause of death in the United States. Around the globe, cancer incidence has been steadily increasing over...
Dec 27, 2019
Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha Ra
Alpha DaRT™ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors. Tel Aviv, Israel,...
Nov 26, 2019
Alpha Tau Medical Appoints Jefferson University Radiation Oncologist Robert Den as Chief Medical Off
Alpha Tau Medical, developer of the breakthrough alpha radiation cancer therapy Alpha DaRT, announced today the appointment of Dr. Robert...
Sep 4, 2019
Prof. Keisari wins Best Oral Presentation Award at ABS Annual Meeting
We're excited that at this year’s American Brachytherapy Society (ABS) Meeting, Prof. Keisari was awarded the Best Oral Presentation...
Jun 18, 2019
Breakthrough Cancer Therapy Developer, Alpha Tau, Awarded ISO 13485 Certificate for Quality Manageme
Alpha Tau Medical, developer of the breakthrough alpha radiation cancer therapy, Alpha DaRT, announced today that it has obtained ISO...
Apr 11, 2019
Cancer Biotech Firm Alpha Tau Medical Appoints Raphi Levy of Goldman Sachs as Chief Financial Office
Tel Aviv, Israel, March 26, 2019 – Alpha Tau Medical, developer of the breakthrough alpha radiation cancer therapy, Alpha DaRT, announced...
Mar 26, 2019
Alpha Tau Medical to Present during the JP Morgan Healthcare Week 2019 in San Francisco
Alpha Tau Medical today announced that it will present at Biotech Showcase™ 2019, to be held January 7–9, during the JP Morgan Healthcare...
Dec 20, 2018
Alpha Tau Medical Launches New Clinical Trials in Italy with Leading Cancer Centers, La Sapienza and
Trials will investigate the efficacy of its breakthrough cancer treatment, Alpha DaRT, in Squamous Cell Carcinoma (SCC) of the Skin, and...
Nov 7, 2018
bottom of page